Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole preemptive genotyping strategy trial in hematology patients at risk of aspergillosis
2019-000376-41Phase 4Active
- Sponsor
- Hospital La Paz Institute for Health Research
- Start
- Apr 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of voriconazole in invasive aspergillosis (IA) and invasive mycoses (2 arms), sponsored by Hospital La Paz Institute for Health Research. Started Apr 2019; status: active.
02
Drugs
voriconazole
03
Conditions
invasive aspergillosis (IA)invasive mycoses
Beyond the preview
Go deeper on 2019-000376-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000376-41.